Physician profile
David Bianchi
NPI 1821022690
$5,272.42
in general payments reported to CMS, 2019-2025
25 companies · $729 in 2025
The $729 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $260 · 2021: $151 · 2022: $505 · 2023: $499 · 2024: $2,466 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,537 · Travel and Lodging: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,536.88 |
| Travel and Lodging | $1,156.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,675.30 | 2019-2025 | Scopis Ent, Clarifix Cryotherapy Device, Latera |
| Inspire Medical Systems, INC. | $733.14 | 2023-2025 | Inspire |
| Integra Lifesciences Corporation | $488.30 | 2021-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Regeneron Healthcare Solutions, INC. | $405.60 | 2019-2025 | Dupixent |
| Genzyme Corporation | $334.87 | 2020-2025 | |
| Optinose US, INC. | $272.99 | 2019-2023 | |
| Hill Dermaceuticals, INC. | $266.86 | 2021-2022 | |
| Aerin Medical INC. | $220.86 | 2023-2025 | |
| Glaxosmithkline, LLC. | $215.38 | 2022-2025 | Nucala |
| Acclarent, INC | $201.62 | 2019-2022 | |
| Medtronic USA, INC. | $128.63 | 2019 | |
| Smith+Nephew, INC. | $52.12 | 2020-2021 | |
| Medtronic, INC. | $37.70 | 2024 | Propel |
| Merck Sharp & Dohme LLC | $29.15 | 2021-2023 | |
| Hikma Pharmaceuticals USA | $28.78 | 2023-2024 | Ryaltris |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $28.63 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Kaleo, INC. | $25.29 | 2023 | Auvi-Q |
| Ars Pharmaceuticals Operations, INC. | $21.11 | 2025 | Neffy |
| Alk-Abello, INC | $18.88 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $18.69 | 2025 | |
| Amgen INC. | $18.00 | 2025 | Tezspire |
| Ethicon US, LLC | $13.84 | 2022 | |
| Checkpoint Surgical, INC | $13.75 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.63 | 2019 | |
| Itamar Medical INC | $10.30 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bianchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.